Our results revealed that the ITGA2 BglII +/+ genotype was significantly overexpressed in patients with grade II astrocytoma compared to controls, OR (95% CI) 4.38 (1.31–14.72) and P = 0.02 (Table 2). This evidence concerns the gene ITGA2 and astrocytoma (excluding glioblastoma).